Estudo randomizado | Efeito da semaglutida 1 vez/semana vs. insulina aspart 3 vezes/dia, ambas adicionadas à metformina e ao tratamento otimizado com insulina glargina em participantes com diabetes tipo 2. 9 Ago, 2022 | 17:34h Effect of once-weekly semaglutide versus thrice-daily insulin aspart, both as add-on to metformin and optimized insulin glargine treatment in participants with type 2 diabetes (SUSTAIN 11): A randomized, open-label, multinational, phase 3b trial – Diabetes, Obesity and Metabolism